FDA Rule Change Could Hold Generic Drug Manufacturers Liable
By Michael Barasch
In 2004, Nancy Bartlett, a secretary for a New Hampshire insurance company visited her doctor complaining of shoulder pain and was prescribed the non-steroidal anti-inflammatory drug Clinoril. Ms. Bartlett received the generic version, sulindac, from her pharmacist. Shortly after, Ms. Bartlett suffered Stevens-Johnson syndrome, a severe drug reaction that caused two-thirds of her skin to […]
